The International Monetary Fund (IMF) has invited a number of renowned economists, academicians and former senior government officials to Washington for consultations on a future roadmap on economic challenges of Pakistan and possibility for extending another bailout package in case Islamabad made a
Oil prices fell below $70 a barrel in New York for the first time in more than two weeks as Saudi Arabia said it expects Opec and its partners to boost supplies later this year, easing restraints intact since early 2017.
Global oil prices fell yesterday after top producer Saudi Arabia signalled a likely boost in supply as soon as the third quarter, and world stock markets were mixed over the sudden US move to cancel the summit with North Korea.
Foreign banks are circling Australia once more as they bet on resources and infrastructure investment gathering pace at a time when local banks are distracted by a government inquiry following a string of scandals.
China plans to use cornerstone investors to help its overseas-listed tech giants such as Alibaba and Xiaomi to sell shares at home, on worries the size of the deals could overwhelm mainland markets, three sources said.
Seattle levied an annual tax of about $50mn on big companies last week to help solve the city’s homeless problem. The tax was watered down from the original proposal but it was controversial and pitted the city against its most powerful corporate resident, Amazon.com Inc.
Ifo: Downward trend stopped, economy holding ground; economist: German growth story on its last leg; US tariffs, US exit from Iran deal are risks; other recent data shows economic growth slowing
When Tadashi Kikugawa arrived on the Japanese bond desk at Fuji Bank in 1988 after finishing a college degree in physics, he had to get to grips with a market with “huge” fluctuations. Trades worth $1bn in one shot weren’t unusual, he says, and they would often send yields seesawing.
Toshiba Corp may need to do more to regain investors’ confidence if it wants to reestablish itself as a regular issuer in Japan’s bond market.
Drugmakers, whose industry pricing faced renewed scorn this month from President Donald Trump, have been taking advantage of the US tax overhaul he signed last year to buy back shares of their own underperforming stocks.